within Pharmacolibrary.Drugs.ATC.P;

model P02CA01
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.02,
    Cl             = 0.0033333333333333335,
    adminDuration  = 600,
    adminMass      = 100 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.0008333333333333334,
    Tlag           = 600
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>P02CA01</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Mebendazole is a broad-spectrum anthelmintic drug used for the treatment of various helminthic infections such as ascariasis, hookworm, whipworm, and pinworm. It is listed as an essential medicine by the WHO and remains an approved and widely used medication for parasitic worm infections in both adults and children.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following a single oral dose.</p><h4>References</h4><ol><li><p>Nguyen, J, et al., &amp; Hoang, BX (2024). Oral Fenbendazole for Cancer Therapy in Humans and Animals. <i>Anticancer research</i> 44(9) 3725–3735. DOI:<a href=\"https://doi.org/10.21873/anticanres.17197\">10.21873/anticanres.17197</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/39197912/\">https://pubmed.ncbi.nlm.nih.gov/39197912</a></p></li><li><p>Yanke, AB, et al., &amp; Boothe, DM (2023). Pharmacokinetics of mebendazole in plasma and cerebrospinal fluid following a single oral dose in healthy dogs. <i>Frontiers in veterinary science</i> 10 1231769–None. DOI:<a href=\"https://doi.org/10.3389/fvets.2023.1231769\">10.3389/fvets.2023.1231769</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/37701529/\">https://pubmed.ncbi.nlm.nih.gov/37701529</a></p></li><li><p>Michiels, M, et al., &amp; van den Bossche, H (1982). The pharmacokinetics of mebendazole and flubendazole in animals and man. <i>Archives internationales de pharmacodynamie et de therapie</i> 256(2) 180–191. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7103610/\">https://pubmed.ncbi.nlm.nih.gov/7103610</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end P02CA01;
